Methotrexate Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 03/13/2023. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0703-3671-01
- Dosage Form
- Injection
- Presentation
- Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)
- Initial Posting
- 03/13/2023
- Revised Date
Reason
Other